glp 1 receptor drugs GLP-1 Agonists: A Comprehensive Overview Benefits and Risks of GLP-1
Description
Side Effects: Gastrointestinal symptoms are the leading reason for non-adherence
Research on GLP-1 Medications for Treating SUDs Animal studies consistently demonstrate GLP-1 receptor agonists reduce alcohol, nicotine, and opioid consumption (Srinivasan et al., 2025)
2022;37(18):e146
2024;22(6):1226-37 e14
But not every company with expertise in making peptides plans to dive into the generics business
For retatrutide, that is 24 to 30 days at a given dose
